Michael York Phase Bio Pharmaceuticals Inc (PHAS) insider trading activity

PHAS Quotes by TradingView

Michael York is VP, Corporate Development of PhaseBio Pharmaceuticals Inc. Currently has a direct ownership of 7,059 shares of PHAS, which is worth approximately $0. The most recent transaction as insider was on May 20, 2021, when has been sold 2,897 shares (Common Stock) at a price of $2.8 per share, resulting in proceeds of $8,112. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.06K
0% 3M change
0% 12M change
Total Value Held $0

Michael York Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2021
BUY
Grant, award, or other acquisition
$8,112 $2.8 p/Share
2,897 Added 29.1%
7,059 Common Stock
Nov 20 2020
BUY
Grant, award, or other acquisition
$7,986 $3.0 p/Share
2,662 Added 39.01%
4,162 Common Stock

Also insider at

MTCR
Metacrine, Inc. Healthcare
Chief Business Officer
MY

Michael York

VP, Corporate Development
Malvern, PA

Track Institutional and Insider Activities on PHAS

Follow PhaseBio Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHAS shares.

Notify only if

Insider Trading

Get notified when an Phase Bio Pharmaceuticals Inc insider buys or sells PHAS shares.

Notify only if

News

Receive news related to PhaseBio Pharmaceuticals Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PHAS